Ironwood Pharmaceuticals, Inc. (IRWD) Stock Forecast
Data as of Jun 17, 2026Healthcare · Current price $3.71 (+0.41%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Feb 26, 2026 | Amy Li | Jefferies | $3.70 | -0.1% |
| Apr 14, 2025 | Faisal Khurshid | Leerink Partners | $1.00 | -73.0% |
| Jan 31, 2025 | Mohit Bansal | Wells Fargo | $7.00 | +88.9% |
| Sep 9, 2024 | Faisal Khurshid | Leerink Partners | $5.00 | +35.0% |
| Aug 9, 2024 | Mohit Bansal | Wells Fargo | $12.00 | +223.9% |
| May 22, 2024 | David Amsellem | Piper Sandler | $18.00 | +385.8% |
| May 22, 2024 | Mohit Bansal | Wells Fargo | $14.00 | +277.9% |
| Apr 22, 2022 | David Amsellem | Piper Sandler | $16.00 | +331.8% |
Top Analysts Covering IRWD
IRWD vs Sector & Market
| Metric | IRWD | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.33 | 2.24 | 2.40 |
| Analyst Count | 3 | 8 | 19 |
| Target Upside | +31.7% | +11475.0% | +17.1% |
| P/E Ratio | 6.20 | 3.90 | 31.64 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $455M | $460M | $465M | 3 |
| 2027-03-31 | $99M | $103M | $111M | 1 |
| 2027-06-30 | $121M | $127M | $137M | 1 |
| 2027-09-30 | $123M | $128M | $139M | 1 |
| 2027-12-31 | $127M | $133M | $144M | 1 |
| 2028-03-31 | $103M | $108M | $117M | 1 |
| 2028-06-30 | $127M | $133M | $144M | 1 |
| 2028-09-30 | $129M | $135M | $146M | 1 |
| 2028-12-31 | $134M | $140M | $151M | 1 |
| 2029-12-31 | $250M | $253M | $256M | 2 |
| 2030-12-31 | $234M | $237M | $240M | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $1.26 | $1.28 | $1.30 | 2 |
| 2027-03-31 | $0.22 | $0.23 | $0.25 | 1 |
| 2027-06-30 | $0.32 | $0.34 | $0.38 | 1 |
| 2027-09-30 | $0.33 | $0.35 | $0.39 | 1 |
| 2027-12-31 | $0.35 | $0.37 | $0.41 | 1 |
| 2028-03-31 | $0.27 | $0.29 | $0.32 | 1 |
| 2028-06-30 | $0.37 | $0.39 | $0.43 | 1 |
| 2028-09-30 | $0.38 | $0.40 | $0.44 | 1 |
| 2028-12-31 | $0.40 | $0.42 | $0.46 | 1 |
| 2029-12-31 | $0.47 | $0.48 | $0.49 | 1 |
| 2030-12-31 | $0.60 | $0.60 | $0.61 | 1 |
Frequently Asked Questions
What is the analyst consensus for IRWD?
The consensus among 3 analysts covering Ironwood Pharmaceuticals, Inc. (IRWD) is Buy with an average price target of $4.80.
What is the highest price target for IRWD?
The highest price target for IRWD is $18.00, set by David Amsellem at Piper Sandler on 2024-05-22.
What is the lowest price target for IRWD?
The lowest price target for IRWD is $1.00, set by Faisal Khurshid at Leerink Partners on 2025-04-14.
How many analysts cover IRWD?
3 analysts have issued ratings for Ironwood Pharmaceuticals, Inc. in the past 12 months.
Is IRWD a buy or sell right now?
Based on 3 analyst ratings, IRWD has a consensus rating of Buy (2.33/5) with a +31.7% upside to the consensus target of $4.80.
What are the earnings estimates for IRWD?
Analysts estimate IRWD will report EPS of $1.28 for the period ending 2026-12-31, with revenue estimated at $460M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.